|
Fralex Therapeutics, Inc. |
|
|
190 Attwell Drive, Suite 580
Toronto, Ontario M9W 6H8 CAN
phone:416-213-8118
fax:416-213-8668
|
|
| Symbol |
FXI |
| Exchange |
TSX |
| Founded |
1998 |
| Employees |
|
|
|
| www.fralex.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Developing therapy for the treatment of chronic pain, depression and anxiety. |
|
| Management |
| Avi Grewal - President and Chief Executive Officer; Leslie Auld - Chief Financial Officer; Dr. Sesh M. Chari - Chief Operating Officer ; Dr. Alex Thomas, PhD - Vice President, Research
|
| |
|
|
|
|
|
|
|
| Keywords |
| neuroscience, chronic pain, advamed, depression
|
|
|
|
| Description |
|
Fralex Therapeutics Inc. is dedicated to improving quality of life through the use of neuromodulation therapy. Our technology - known as the Complex Neural Pulse (CNP) - is being developed as a non-drug alternative for the treatment of chronic pain. |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members
